nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—Snoring—Varenicline—nicotine dependence	0.0434	0.0529	CcSEcCtD
Donepezil—Postnasal drip—Varenicline—nicotine dependence	0.0407	0.0496	CcSEcCtD
Donepezil—Upper-airway cough syndrome—Varenicline—nicotine dependence	0.0345	0.042	CcSEcCtD
Donepezil—Pleurisy—Varenicline—nicotine dependence	0.0258	0.0315	CcSEcCtD
Donepezil—Tetrabenazine—DRD2—nicotine dependence	0.0228	1	CrCbGaD
Donepezil—Polydipsia—Varenicline—nicotine dependence	0.0203	0.0248	CcSEcCtD
Donepezil—Respiratory tract congestion—Varenicline—nicotine dependence	0.0173	0.021	CcSEcCtD
Donepezil—Dysphoria—Varenicline—nicotine dependence	0.0146	0.0178	CcSEcCtD
Donepezil—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0128	0.0157	CcSEcCtD
Donepezil—Transient ischaemic attack—Varenicline—nicotine dependence	0.0125	0.0152	CcSEcCtD
Donepezil—Night sweats—Varenicline—nicotine dependence	0.0117	0.0142	CcSEcCtD
Donepezil—Hostility—Varenicline—nicotine dependence	0.0114	0.0139	CcSEcCtD
Donepezil—Osteoporosis—Varenicline—nicotine dependence	0.0112	0.0137	CcSEcCtD
Donepezil—Gastric ulcer—Varenicline—nicotine dependence	0.0108	0.0132	CcSEcCtD
Donepezil—Libido increased—Varenicline—nicotine dependence	0.0103	0.0126	CcSEcCtD
Donepezil—Toothache—Varenicline—nicotine dependence	0.0103	0.0126	CcSEcCtD
Donepezil—Psoriasis—Varenicline—nicotine dependence	0.01	0.0122	CcSEcCtD
Donepezil—Upset stomach—Varenicline—nicotine dependence	0.00961	0.0117	CcSEcCtD
Donepezil—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00961	0.0117	CcSEcCtD
Donepezil—Cyst—Varenicline—nicotine dependence	0.00942	0.0115	CcSEcCtD
Donepezil—Paranoia—Varenicline—nicotine dependence	0.00923	0.0113	CcSEcCtD
Donepezil—Delusion—Varenicline—nicotine dependence	0.00889	0.0108	CcSEcCtD
Donepezil—Nystagmus—Varenicline—nicotine dependence	0.00881	0.0108	CcSEcCtD
Donepezil—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00881	0.0559	CbGpPWpGaD
Donepezil—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00874	0.0554	CbGpPWpGaD
Donepezil—Hyperlipidaemia—Varenicline—nicotine dependence	0.00873	0.0107	CcSEcCtD
Donepezil—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00836	0.0102	CcSEcCtD
Donepezil—Fungal infection—Varenicline—nicotine dependence	0.00815	0.00995	CcSEcCtD
Donepezil—Gingivitis—Varenicline—nicotine dependence	0.00802	0.00978	CcSEcCtD
Donepezil—Glycosuria—Varenicline—nicotine dependence	0.00777	0.00948	CcSEcCtD
Donepezil—HRH3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00741	0.047	CbGpPWpGaD
Donepezil—Eye irritation—Varenicline—nicotine dependence	0.00737	0.00899	CcSEcCtD
Donepezil—Aggression—Varenicline—nicotine dependence	0.00716	0.00874	CcSEcCtD
Donepezil—Accidental injury—Varenicline—nicotine dependence	0.00711	0.00868	CcSEcCtD
Donepezil—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00697	0.0085	CcSEcCtD
Donepezil—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00688	0.0436	CbGpPWpGaD
Donepezil—Nocturia—Varenicline—nicotine dependence	0.00679	0.00828	CcSEcCtD
Donepezil—Leukocytosis—Varenicline—nicotine dependence	0.0067	0.00817	CcSEcCtD
Donepezil—Dysarthria—Varenicline—nicotine dependence	0.00666	0.00812	CcSEcCtD
Donepezil—Abnormal dreams—Varenicline—nicotine dependence	0.00622	0.00759	CcSEcCtD
Donepezil—Eructation—Varenicline—nicotine dependence	0.00618	0.00755	CcSEcCtD
Donepezil—Salivary hypersecretion—Varenicline—nicotine dependence	0.00611	0.00746	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00602	0.0382	CbGpPWpGaD
Donepezil—Dry eye—Varenicline—nicotine dependence	0.00581	0.00709	CcSEcCtD
Donepezil—Oesophagitis—Varenicline—nicotine dependence	0.00575	0.00702	CcSEcCtD
Donepezil—Hypertonia—Varenicline—nicotine dependence	0.00552	0.00673	CcSEcCtD
Donepezil—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00546	0.0347	CbGpPWpGaD
Donepezil—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00541	0.0344	CbGpPWpGaD
Donepezil—Euphoric mood—Varenicline—nicotine dependence	0.00541	0.0066	CcSEcCtD
Donepezil—Diabetes mellitus—Varenicline—nicotine dependence	0.00525	0.00641	CcSEcCtD
Donepezil—Eczema—Varenicline—nicotine dependence	0.00508	0.0062	CcSEcCtD
Donepezil—Injury—Varenicline—nicotine dependence	0.00497	0.00606	CcSEcCtD
Donepezil—Libido decreased—Varenicline—nicotine dependence	0.00493	0.00601	CcSEcCtD
Donepezil—Hot flush—Varenicline—nicotine dependence	0.00488	0.00596	CcSEcCtD
Donepezil—Increased appetite—Varenicline—nicotine dependence	0.00486	0.00593	CcSEcCtD
Donepezil—Menopausal symptoms—Varenicline—nicotine dependence	0.00484	0.00591	CcSEcCtD
Donepezil—Atrial fibrillation—Varenicline—nicotine dependence	0.00482	0.00588	CcSEcCtD
Donepezil—Thirst—Varenicline—nicotine dependence	0.0048	0.00586	CcSEcCtD
Donepezil—Arthritis—Varenicline—nicotine dependence	0.0047	0.00574	CcSEcCtD
Donepezil—Hypoglycaemia—Varenicline—nicotine dependence	0.00468	0.00571	CcSEcCtD
Donepezil—Cerebrovascular accident—Varenicline—nicotine dependence	0.00466	0.00569	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00457	0.00557	CcSEcCtD
Donepezil—Osteoarthritis—Varenicline—nicotine dependence	0.00457	0.00557	CcSEcCtD
Donepezil—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00453	0.00553	CcSEcCtD
Donepezil—Affect lability—Varenicline—nicotine dependence	0.0045	0.00549	CcSEcCtD
Donepezil—Psychotic disorder—Varenicline—nicotine dependence	0.00446	0.00544	CcSEcCtD
Donepezil—Irritability—Varenicline—nicotine dependence	0.00436	0.00532	CcSEcCtD
Donepezil—Urinary retention—Varenicline—nicotine dependence	0.00434	0.0053	CcSEcCtD
Donepezil—Mood swings—Varenicline—nicotine dependence	0.00433	0.00528	CcSEcCtD
Donepezil—Liver function test abnormal—Varenicline—nicotine dependence	0.00422	0.00515	CcSEcCtD
Donepezil—Dry skin—Varenicline—nicotine dependence	0.00419	0.00511	CcSEcCtD
Donepezil—Abdominal pain upper—Varenicline—nicotine dependence	0.00417	0.00509	CcSEcCtD
Donepezil—Hypokalaemia—Varenicline—nicotine dependence	0.00416	0.00507	CcSEcCtD
Donepezil—Cramp muscle—Varenicline—nicotine dependence	0.00411	0.00502	CcSEcCtD
Donepezil—Nasopharyngitis—Varenicline—nicotine dependence	0.00409	0.00498	CcSEcCtD
Donepezil—Gastritis—Varenicline—nicotine dependence	0.00404	0.00493	CcSEcCtD
Donepezil—Abdominal distension—Varenicline—nicotine dependence	0.00398	0.00485	CcSEcCtD
Donepezil—Asthma—Varenicline—nicotine dependence	0.00395	0.00482	CcSEcCtD
Donepezil—Dysphagia—Varenicline—nicotine dependence	0.00395	0.00482	CcSEcCtD
Donepezil—Angina pectoris—Varenicline—nicotine dependence	0.00385	0.00469	CcSEcCtD
Donepezil—Bronchitis—Varenicline—nicotine dependence	0.0038	0.00463	CcSEcCtD
Donepezil—Abdominal discomfort—Varenicline—nicotine dependence	0.00379	0.00462	CcSEcCtD
Donepezil—Pollakiuria—Varenicline—nicotine dependence	0.00365	0.00445	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00364	0.0231	CbGpPWpGaD
Donepezil—Weight increased—Varenicline—nicotine dependence	0.00359	0.00438	CcSEcCtD
Donepezil—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00357	0.0227	CbGpPWpGaD
Donepezil—Hyperglycaemia—Varenicline—nicotine dependence	0.00356	0.00435	CcSEcCtD
Donepezil—Infestation NOS—Varenicline—nicotine dependence	0.00352	0.0043	CcSEcCtD
Donepezil—Infestation—Varenicline—nicotine dependence	0.00352	0.0043	CcSEcCtD
Donepezil—Depression—Varenicline—nicotine dependence	0.00351	0.00428	CcSEcCtD
Donepezil—Acute coronary syndrome—Varenicline—nicotine dependence	0.00347	0.00423	CcSEcCtD
Donepezil—Myocardial infarction—Varenicline—nicotine dependence	0.00345	0.00421	CcSEcCtD
Donepezil—Conjunctivitis—Varenicline—nicotine dependence	0.00342	0.00418	CcSEcCtD
Donepezil—Epistaxis—Varenicline—nicotine dependence	0.00332	0.00405	CcSEcCtD
Donepezil—Bradycardia—Varenicline—nicotine dependence	0.00322	0.00393	CcSEcCtD
Donepezil—Hypoaesthesia—Varenicline—nicotine dependence	0.00315	0.00384	CcSEcCtD
Donepezil—Hallucination—Varenicline—nicotine dependence	0.00315	0.00384	CcSEcCtD
Donepezil—Urinary tract disorder—Varenicline—nicotine dependence	0.00312	0.00381	CcSEcCtD
Donepezil—Oedema peripheral—Varenicline—nicotine dependence	0.00311	0.0038	CcSEcCtD
Donepezil—Urethral disorder—Varenicline—nicotine dependence	0.0031	0.00378	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00308	0.0195	CbGpPWpGaD
Donepezil—Visual impairment—Varenicline—nicotine dependence	0.00305	0.00372	CcSEcCtD
Donepezil—Tinnitus—Varenicline—nicotine dependence	0.00295	0.0036	CcSEcCtD
Donepezil—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00292	0.0185	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00292	0.0185	CbGpPWpGaD
Donepezil—Chills—Varenicline—nicotine dependence	0.00284	0.00346	CcSEcCtD
Donepezil—Arrhythmia—Varenicline—nicotine dependence	0.00282	0.00345	CcSEcCtD
Donepezil—Mental disorder—Varenicline—nicotine dependence	0.00277	0.00338	CcSEcCtD
Donepezil—Erythema—Varenicline—nicotine dependence	0.00275	0.00336	CcSEcCtD
Donepezil—Malnutrition—Varenicline—nicotine dependence	0.00275	0.00336	CcSEcCtD
Donepezil—Flatulence—Varenicline—nicotine dependence	0.00271	0.00331	CcSEcCtD
Donepezil—Dysgeusia—Varenicline—nicotine dependence	0.00269	0.00329	CcSEcCtD
Donepezil—Back pain—Varenicline—nicotine dependence	0.00266	0.00325	CcSEcCtD
Donepezil—Muscle spasms—Varenicline—nicotine dependence	0.00265	0.00323	CcSEcCtD
Donepezil—Vision blurred—Varenicline—nicotine dependence	0.00259	0.00316	CcSEcCtD
Donepezil—Tremor—Varenicline—nicotine dependence	0.00258	0.00315	CcSEcCtD
Donepezil—Ill-defined disorder—Varenicline—nicotine dependence	0.00255	0.00311	CcSEcCtD
Donepezil—Anaemia—Varenicline—nicotine dependence	0.00254	0.0031	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00254	0.0161	CbGpPWpGaD
Donepezil—Agitation—Varenicline—nicotine dependence	0.00253	0.00309	CcSEcCtD
Donepezil—Malaise—Varenicline—nicotine dependence	0.00248	0.00303	CcSEcCtD
Donepezil—Vertigo—Varenicline—nicotine dependence	0.00247	0.00302	CcSEcCtD
Donepezil—Syncope—Varenicline—nicotine dependence	0.00247	0.00301	CcSEcCtD
Donepezil—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00245	0.0156	CbGpPWpGaD
Donepezil—Loss of consciousness—Varenicline—nicotine dependence	0.00242	0.00295	CcSEcCtD
Donepezil—Cough—Varenicline—nicotine dependence	0.0024	0.00293	CcSEcCtD
Donepezil—Convulsion—Varenicline—nicotine dependence	0.00238	0.00291	CcSEcCtD
Donepezil—Hypertension—Varenicline—nicotine dependence	0.00238	0.0029	CcSEcCtD
Donepezil—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00236	0.015	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00235	0.0149	CbGpPWpGaD
Donepezil—Chest pain—Varenicline—nicotine dependence	0.00234	0.00286	CcSEcCtD
Donepezil—Arthralgia—Varenicline—nicotine dependence	0.00234	0.00286	CcSEcCtD
Donepezil—Myalgia—Varenicline—nicotine dependence	0.00234	0.00286	CcSEcCtD
Donepezil—Anxiety—Varenicline—nicotine dependence	0.00233	0.00285	CcSEcCtD
Donepezil—Discomfort—Varenicline—nicotine dependence	0.00231	0.00282	CcSEcCtD
Donepezil—Dry mouth—Varenicline—nicotine dependence	0.00229	0.0028	CcSEcCtD
Donepezil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00227	0.0144	CbGpPWpGaD
Donepezil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00225	0.0143	CbGpPWpGaD
Donepezil—Oedema—Varenicline—nicotine dependence	0.00225	0.00274	CcSEcCtD
Donepezil—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00224	0.0142	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00224	0.0142	CbGpPWpGaD
Donepezil—Infection—Varenicline—nicotine dependence	0.00223	0.00272	CcSEcCtD
Donepezil—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00222	0.0141	CbGpPWpGaD
Donepezil—Shock—Varenicline—nicotine dependence	0.00221	0.0027	CcSEcCtD
Donepezil—Nervous system disorder—Varenicline—nicotine dependence	0.0022	0.00269	CcSEcCtD
Donepezil—Thrombocytopenia—Varenicline—nicotine dependence	0.0022	0.00268	CcSEcCtD
Donepezil—Hyperhidrosis—Varenicline—nicotine dependence	0.00217	0.00265	CcSEcCtD
Donepezil—Anorexia—Varenicline—nicotine dependence	0.00214	0.00261	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00211	0.0134	CbGpPWpGaD
Donepezil—Hypotension—Varenicline—nicotine dependence	0.0021	0.00256	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00206	0.0131	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00205	0.0025	CcSEcCtD
Donepezil—Insomnia—Varenicline—nicotine dependence	0.00203	0.00248	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00202	0.0128	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00202	0.0128	CbGpPWpGaD
Donepezil—Dyspnoea—Varenicline—nicotine dependence	0.002	0.00244	CcSEcCtD
Donepezil—Somnolence—Varenicline—nicotine dependence	0.002	0.00244	CcSEcCtD
Donepezil—Dyspepsia—Varenicline—nicotine dependence	0.00198	0.00241	CcSEcCtD
Donepezil—Decreased appetite—Varenicline—nicotine dependence	0.00195	0.00238	CcSEcCtD
Donepezil—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00194	0.00237	CcSEcCtD
Donepezil—Fatigue—Varenicline—nicotine dependence	0.00194	0.00236	CcSEcCtD
Donepezil—Pain—Varenicline—nicotine dependence	0.00192	0.00234	CcSEcCtD
Donepezil—Constipation—Varenicline—nicotine dependence	0.00192	0.00234	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00188	0.0119	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00187	0.0119	CbGpPWpGaD
Donepezil—Feeling abnormal—Varenicline—nicotine dependence	0.00185	0.00226	CcSEcCtD
Donepezil—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00184	0.0117	CbGpPWpGaD
Donepezil—Gastrointestinal pain—Varenicline—nicotine dependence	0.00184	0.00224	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—DRD2—nicotine dependence	0.00183	0.0116	CbGpPWpGaD
Donepezil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00182	0.0116	CbGpPWpGaD
Donepezil—Urticaria—Varenicline—nicotine dependence	0.00178	0.00218	CcSEcCtD
Donepezil—Body temperature increased—Varenicline—nicotine dependence	0.00178	0.00217	CcSEcCtD
Donepezil—Abdominal pain—Varenicline—nicotine dependence	0.00178	0.00217	CcSEcCtD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00171	0.0108	CbGpPWpGaD
Donepezil—HRH3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.0017	0.0108	CbGpPWpGaD
Donepezil—Hypersensitivity—Varenicline—nicotine dependence	0.00165	0.00202	CcSEcCtD
Donepezil—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00162	0.0103	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—FGD1—nicotine dependence	0.00162	0.0103	CbGpPWpGaD
Donepezil—Asthenia—Varenicline—nicotine dependence	0.00161	0.00197	CcSEcCtD
Donepezil—Pruritus—Varenicline—nicotine dependence	0.00159	0.00194	CcSEcCtD
Donepezil—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00155	0.00984	CbGpPWpGaD
Donepezil—Diarrhoea—Varenicline—nicotine dependence	0.00154	0.00187	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—OPRM1—nicotine dependence	0.00154	0.00975	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00153	0.00973	CbGpPWpGaD
Donepezil—Dizziness—Varenicline—nicotine dependence	0.00149	0.00181	CcSEcCtD
Donepezil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00148	0.00941	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—FGD1—nicotine dependence	0.00147	0.00931	CbGpPWpGaD
Donepezil—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00146	0.00929	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00146	0.00925	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.00144	0.00915	CbGpPWpGaD
Donepezil—Vomiting—Varenicline—nicotine dependence	0.00143	0.00174	CcSEcCtD
Donepezil—Rash—Varenicline—nicotine dependence	0.00142	0.00173	CcSEcCtD
Donepezil—Dermatitis—Varenicline—nicotine dependence	0.00141	0.00173	CcSEcCtD
Donepezil—Headache—Varenicline—nicotine dependence	0.00141	0.00172	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00135	0.00857	CbGpPWpGaD
Donepezil—Nausea—Varenicline—nicotine dependence	0.00133	0.00163	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00123	0.00778	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00121	0.00765	CbGpPWpGaD
Donepezil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0012	0.00763	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.00117	0.00746	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00114	0.00723	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—DRD2—nicotine dependence	0.00111	0.00705	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TAS2R16—nicotine dependence	0.0011	0.00701	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00104	0.00658	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00103	0.00657	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.00103	0.00657	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00103	0.00652	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000977	0.0062	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000968	0.00615	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000963	0.00611	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000955	0.00606	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000939	0.00596	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000868	0.00551	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGD1—nicotine dependence	0.000867	0.0055	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—OPRM1—nicotine dependence	0.000788	0.005	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000779	0.00495	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKR1B10—nicotine dependence	0.000765	0.00486	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000682	0.00433	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000677	0.0043	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000668	0.00424	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000639	0.00405	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00063	0.004	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—DRD2—nicotine dependence	0.000627	0.00398	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000619	0.00393	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—DRD2—nicotine dependence	0.00057	0.00362	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000563	0.00358	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—WASF2—nicotine dependence	0.000539	0.00342	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000535	0.00339	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—WASF1—nicotine dependence	0.000517	0.00328	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000508	0.00323	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000486	0.00308	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000483	0.00306	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—OPRM1—nicotine dependence	0.000466	0.00295	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000407	0.00258	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000368	0.00233	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000366	0.00232	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—DRD2—nicotine dependence	0.000337	0.00214	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000287	0.00182	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.000287	0.00182	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000261	0.00166	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000253	0.00161	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000208	0.00132	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.000189	0.0012	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.000179	0.00113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000171	0.00109	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000167	0.00106	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000166	0.00105	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.000154	0.000978	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DRD2—nicotine dependence	0.000111	0.000707	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000109	0.000693	CbGpPWpGaD
